Mealey's (July 12, 2021, 1:49 PM EDT) -- SAN FRANCISCO — The Ninth Circuit U.S. Court of Appeals on July 9 affirmed dismissal of a whistle-blower’s claims against two drug companies for off-label promotion of two drugs, saying the relator failed to sufficiently allege that he had “direct and independent” knowledge of the defendants’ alleged fraud....